6.35

1.44% +0.10

Essa Pharma Inc (EPIX)

Overview News Price History Option Chain Discussions Forecast Stock Split

Essa Pharma Inc stock is currently priced at $6.35, with a 24-hour trading volume of 6,130. It has seen a +1.44% increased in the last 24 hours and a -29.87% declined in the past month. The chart indicates a potential bearish trend, as the stock is below the $6.36 pivot point. If it approaches the $6.15 support level, significant changes may occur.

Previous Close:

$6.25

Open:

$6.18

24h Volume:

6,130

Market Cap:

$280.91M

Revenue:

Net Income/Loss:

$-25.80M

P/E Ratio:

-10.24

EPS:

-0.62

Net Cash Flow:

$-22.19M

1W Performance:

-5.65%

1M Performance:

-29.87%

6M Performance:

+56.74%

1Y Performance:

+136.57%

1D Range:

$6.01

$6.3645

52W Range:

$2.56

$11.67

Essa Pharma Inc Stock (EPIX) Company Profile

Name

Essa Pharma Inc

Sector

Healthcare (1201)

Industry

Biotechnology (688)

Phone

778-331-0962

Address

999 West Broadway, Suite 720, Vancouver, BC

Employee

Twitter

@essapharma

Next Earnings Date

2024-05-07

Latest SEC Filings

EPIX's Discussions on Twitter

Essa Pharma Inc Stock (EPIX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jun-26-23	Resumed	Oppenheimer	Outperform
Mar-04-21	Initiated	Piper Sandler	Overweight
Jan-11-21	Reiterated	H.C. Wainwright	Buy
Nov-02-20	Initiated	Jefferies	Buy
Oct-25-19	Initiated	Oppenheimer	Outperform

Essa Pharma Inc Stock (EPIX) Latest News

Booz Allen Hamilton Posts Upbeat Results, Joins AppFolio, Gentex And Other Big Stocks Moving Higher On Friday

Benzinga

Why Humana Shares Are Trading Lower By Over 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Benzinga

Applied Digital, ESSA Pharma And Other Big Stocks Moving Higher In Tuesday's Pre-Market Session

Benzinga

Essa Pharma Inc Stock (EPIX) Financials Data

Essa Pharma Inc (EPIX) Net Income 2024

EPIX net income (TTM) was -$25.80 million for the quarter ending December 31, 2023, a +21.20% increase year-over-year.

Essa Pharma Inc (EPIX) Cash Flow 2024

EPIX recorded a free cash flow (TTM) of -$22.19 million for the quarter ending December 31, 2023, a +16.44% increase year-over-year.

Essa Pharma Inc (EPIX) Earnings per Share 2024

EPIX earnings per share (TTM) was -$0.59 for the quarter ending December 31, 2023, a +20.27% growth year-over-year.

ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on the development of novel therapeutics for the treatment of prostate cancer. It is developing EPI-506 that is in Phase 1/2 clinical trials for the treatment of prostate cancer. The company was founded in 2009 and is headquartered in Vancouver, Canada.